Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells

Marica Rosaria. Ippolito,Johanna Zerbib,Yonatan Eliezer,Eli Reuveni,Sonia Vigano,Giuseppina De Feudis,Eldad D. Shulman,Anouk Savir Kadmon,Rachel Slutsky,Tiangen Chang,Emma M. Campagnolo,Silvia Taglietti,Simone Scorzoni,Sara Gianotti,Sara Martin,Julia Muenzner,Michael Mulleder,Nir Rozenblum,Carmela Rubolino,Tal Ben-Yishay,Kathrin Laue,Yael Cohen-Sharir,Ilaria Vigorito,Francesco Nicassio,Eytan Ruppin,Markus Ralser,Francisca Vazquez,Stefano Santaguida,Uri Ben-David

DOI: https://doi.org/10.1158/2159-8290.cd-23-0309

IF: 28.2

2024-09-11

Cancer Discovery

Abstract:Aneuploidy results in a stoichiometric imbalance of protein complexes that jeopardizes cellular fitness. Aneuploid cells thus need to compensate for the imbalanced DNA levels by regulating their RNA and protein levels, but the underlying molecular mechanisms remain unknown. Here, we dissected multiple diploid vs. aneuploid cell models. We found that aneuploid cells cope with transcriptional burden by increasing several RNA degradation pathways, and are consequently more sensitive to the perturbation of RNA degradation. At the protein level, aneuploid cells mitigate proteotoxic stress by reducing protein translation and increasing protein degradation, rendering them more sensitive to proteasome inhibition. These findings were recapitulated across hundreds of human cancer cell lines and primary tumors, and aneuploidy levels were significantly associated with the response of multiple myeloma patients to proteasome inhibitors. Aneuploid cells are therefore preferentially dependent on several key nodes along the gene expression process, creating clinically-actionable vulnerabilities in aneuploid cells.

oncology